Collier Kathryn J (CIK 1737436) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-27). Recent activity: Sell RGLS (75,565 shares), Buy RGLS (1,396 shares), Buy RGLS (2,604 shares), Buy RGLS (2,325 shares), Buy RGLS (62,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-27 | Regulus Therapeutics Inc. (RGLS) | Director | Sell | 75,565 | $0 |
| 2025-06-18 | Regulus Therapeutics Inc. (RGLS) | Director | Buy | 1,396 | $13,820 |
| 2025-06-18 | Regulus Therapeutics Inc. (RGLS) | Director | Buy | 2,604 | $25,780 |
| 2025-06-18 | Regulus Therapeutics Inc. (RGLS) | Director | Buy | 2,325 | $20,460 |
| 2025-04-30 | Regulus Therapeutics Inc. (RGLS) | Director | Buy | 62,500 | $0 |
Source: SEC Form 4 filings · as of 2025-06-27